Screener
Axsome Therapeutics AXSM Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Axsome Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342360
FAQ
- What is Axsome Therapeutics's operating lease liabilities (current)?
- Axsome Therapeutics (AXSM) reported operating lease liabilities (current) of $646K in Q2 2026.
- How has Axsome Therapeutics's operating lease liabilities (current) changed year-over-year?
- Axsome Therapeutics's operating lease liabilities (current) increased by 91.7% year-over-year, from $337K to $646K.
- What is the long-term trend for Axsome Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Axsome Therapeutics's operating lease liabilities (current) has grown at a -18.7% compound annual growth rate (CAGR), from $1.22M to $434K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Axsome Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude